Outcomes of lung transplantation using TorEx ex-vivo lung perfusion
Haruchika Yamamoto, Aadil Ali, Gabriel Siebiger, Elliot Wakeam, Laura Donahoe, Jonathan C Yeung, Andrew Pierre, Marc de Perrot, Kazuhiro Yasufuku, Thomas K Waddell, Shaf Keshavjee, Marcelo Cypel · 2026
Read Outcomes of lung transplantation using TorEx ex-vivo lung perfusion by Haruchika Yamamoto, Aadil Ali, Gabriel Siebiger, Elliot Wakeam, Laura Donahoe, Jonathan C Yeung, Andrew Pierre, Marc de Perrot, Kazuhiro Yasufuku, Thomas K Waddell, Shaf Keshavjee, Marcelo Cypel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13396924.txt.
Description
Haruchika Yamamoto and co-authors report early results with a next-generation machine that keeps donor lungs alive outside the body before transplant. Their 2026 single-center study comes from a Toronto program that has run over 1,000 such perfusions since 2008.
Ex-vivo lung perfusion lets teams test and repair marginal donor lungs instead of discarding them. The newer TorEx system, introduced in December 2022, loads the organ chamber into one all-in-one device, simplifying setup for centers with less experience. Of 1,067 perfusions through September 2024, 193 used TorEx and 874 the first-generation system. Outcomes after transplant were compared between generations and against standard transplants.
Catalog record
| CREATOR | Haruchika Yamamoto, Aadil Ali, Gabriel Siebiger, Elliot Wakeam, Laura Donahoe, Jonathan C Yeung, Andrew Pierre, Marc de Perrot, Kazuhiro Yasufuku, Thomas K Waddell, Shaf Keshavjee, Marcelo Cypel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26298 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |